News & updates
Announcements, education, and updates from the Texas Society of Nephrology.
ASN Kidney Week 2026 heads to Denver, October 21-25
Nephrology's largest annual meeting returns in person at the Colorado Convention Center, with a new Cardiovascular-Kidney-Metabolic Health early program among the highlights.
Read moreFDA expands finerenone (Kerendia) to CKD in type 1 diabetes
The non-steroidal mineralocorticoid receptor antagonist becomes the first in its class approved for chronic kidney disease across both type 1 and type 2 diabetes.
Read moreSparsentan becomes the first FDA-approved therapy for FSGS
A milestone for focal segmental glomerulosclerosis: the dual endothelin and angiotensin receptor antagonist is now labeled specifically for FSGS, moving care beyond off-label options.
Read moreNew therapies advance for IgA nephropathy
The IgA nephropathy pipeline keeps growing, with atacicept under FDA priority review and positive Phase 3 data for complement- and BAFF/APRIL-targeting agents.
Read moreAbstract submissions now open for the 2026 Annual Meeting
Submit your research to present at this year's annual meeting in Austin. Trainees are especially encouraged to apply.
Read moreNew CME webinar series announced for 2026
A monthly series covering the latest in clinical nephrology practice, available to all members at no additional cost.
Read more2026 membership renewals are now live
Renew online to keep your member benefits active for the year, including event discounts and member resources.
Read more